Please login to the form below

Not currently logged in
Email:
Password:

recalls

This page shows the latest recalls news and features for those working in and with pharma, biotech and healthcare.

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

In this instance, the FDA recommended recalls of multiple medicines. While the FDA has not recommended that individuals stop using Zantac and other ranitidine medicines, it did say that those who

Latest news

More from news
Approximately 10 fully matching, plus 183 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics